輸血診斷市場規模、佔有率和成長分析（按產品類型、檢測類型、最終用戶、技術和地區分類）—2026-2033年產業預測

全球輸血診斷市場規模預計在 2024 年達到 51.8 億美元，從 2025 年的 54.7 億美元成長到 2033 年的 85.3 億美元，在預測期（2026-2033 年）內複合年成長率為 5.7%。

由於對安全輸血方法的需求不斷成長以及篩檢技術的進步，全球輸血診斷市場正經歷強勁成長。外科手術、創傷病例和慢性疾病的增加，對準確可靠的診斷提出了更高的要求。各國政府和醫療機構不斷加強捐血篩檢和病原體檢測，進一步推動了市場的擴張。自動化免疫血液分析儀的普及顯著提高了檢查室效率，最大限度地減少了人為錯誤。此外，核酸增幅檢查(NAT) 等創新技術透過檢測傳染性病原體，增強了血液安全性。我們也見證了多層次分子檢測、病原體減少系統和快速診斷試劑盒的出現，同時，數位化連接和資料管理系統正在改善血液學檢查室的監測、報告和合規性。

全球輸血診斷市場促進因素

全球輸血診斷市場的主要促進因素之一是血液傳播疾病的增加以及人們對安全輸血實踐意識的提高。由於愛滋病、乙型肝炎和丙型肝炎等感染疾病仍然是全球重要的健康問題，因此對先進診斷檢測的需求日益成長，以確保血液製品的安全性和品質。此外，醫療機構對監管合規性和嚴格安全通訊協定的日益重視，也推動了創新血液篩檢技術和診斷解決方案的應用，從而促進了市場成長。

全球輸血診斷市場面臨的限制因素

全球輸血診斷市場面臨的主要限制因素之一是先進診斷技術和設備的高成本。許多醫療機構，尤其是在發展中地區的醫療機構，預算限制了其投資尖端血液篩檢和檢測解決方案的能力。這種經濟障礙會阻礙快速且準確診斷方法的普及，最終影響病人安全和輸血服務的整體效率。此外，新型診斷產品獲得監管部門核准的複雜性也會進一步阻礙市場准入，並抑制產業創新。

全球輸血診斷市場趨勢

全球輸血診斷市場正呈現自動化和數位化連接日益增強的顯著趨勢。檢查室正擴大採用全自動平台，以簡化檢體處理、檢測和結果解讀等工作流程，從而提高檢測的一致性，並縮短國家血庫和大型醫院等高需求環境下的周轉時間。同時，實驗室資訊管理系統 (LIMS) 和雲端分析工具等數位化工具的整合也日益普及，有助於提高醫療網路間的可追溯性、即時追蹤和資料共用。這種數位化轉型不僅加強了監管合規性，還提高了整體營運效率，從而推動了市場的持續成長。

目錄

介紹

• 調查目標
• 調查範圍
• 定義

調查方法

• 資訊收集
• 二手資料和一手資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態與展望

• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 關鍵投資機會
• 市場生態系統
• 市場吸引力指數（2025）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 技術評估
• 監管環境
• 管道分析

全球輸血診斷市場規模（按產品類型和複合年成長率分類）（2026-2033 年）

• 裝置
• 試劑盒和試劑
• 軟體和服務

全球輸血診斷市場規模（按檢測類型和複合年成長率分類）（2026-2033 年）

• 傳染病篩檢（TTIs）
• 血型鑑定/血型檢測
• 相容性和交叉測試
• 核酸增幅檢查（NAT）
• 其他輸血診斷

全球輸血診斷市場規模（按最終用戶和複合年成長率分類）（2026-2033 年）

• 血庫和輸血服務
• 醫院/臨床檢查室
• 診斷檢查室
• 研究所

全球輸血診斷市場規模（依技術及複合年成長率分類）（2026-2033 年）

• 血清學/免疫檢測
• 分子診斷（PCR/NAT）
• 次世代定序/先進平台
• 自動化、高通量系統

全球輸血診斷市場規模及複合年成長率（2026-2033）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業的市場定位（2025 年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市佔率分析（2025 年）
• 主要企業公司簡介
  • 公司詳情
  • 產品系列分析
  • 依業務板塊進行公司股票分析
  • 2023-2025年營收年比比較

主要企業簡介

• Grifols, SA
• Bio-Rad Laboratories, Inc.
• F. Hoffmann-La Roche Ltd f
• Quotient Limited
• Abbott Laboratories
• Ortho Clinical Diagnostics
• BioMerieux SA
• Siemens Healthineers
• Immucor, Inc.
• Danaher Corporation
• BD（Becton, Dickinson & Company）
• DiaSorin SpA
• Thermo Fisher Scientific Inc.
• BAG Healthcare GmbH
• Merck KGaA
• Sysmex Corporation
• Danaher
• Beckman Coulter Inc.
• Novartis AG
• Fresenius Kabi AG
• Cepheid

結論與建議

Global Blood Transfusion Diagnostics Market size was valued at USD 5.18 Billion in 2024 and is poised to grow from USD 5.47 Billion in 2025 to USD 8.53 Billion by 2033, growing at a CAGR of 5.7% during the forecast period (2026-2033).

The global blood transfusion diagnostics market is experiencing robust growth driven by the increasing demand for safe transfusion methods and advancements in screening technologies. A rise in surgical procedures, trauma cases, and chronic diseases necessitates accurate and reliable diagnostics. Ongoing efforts by governments and healthcare organizations aim to enhance donor screening and pathogen detection, further fueling market expansion. The shift towards automated immunohematology analyzers has significantly improved laboratory efficiency by minimizing human error. Additionally, innovative techniques like nucleic acid amplification testing (NAT) enhance blood safety by detecting infectious agents. The industry is also seeing the emergence of multiprime molecular assays, pathogen-reduction systems, and rapid diagnostic kits, while digital connectivity and data management systems improve monitoring, reporting, and compliance in blood testing laboratories.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Blood Transfusion Diagnostics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Blood Transfusion Diagnostics Market Segments Analysis

Global Blood Transfusion Diagnostics Market is segmented by Product Type, Test Type, End-User, Technology and region. Based on Product Type, the market is segmented into Instruments, Kits & Reagents and Software & Services. Based on Test Type, the market is segmented into Infectious Disease Screening (TTIs), Blood Grouping & Typing, Compatibility & Cross-match Testing, Nucleic Acid Testing (NAT) and Other Transfusion Diagnostics. Based on End-User, the market is segmented into Blood Banks & Transfusion Services, Hospitals / Clinical Labs, Diagnostic Laboratories and Research Institutes. Based on Technology, the market is segmented into Serology / Immunoassay, Molecular Diagnostics (PCR/NAT), Next-Generation Sequencing / Advanced Platforms and Automation & High-Throughput Systems. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Blood Transfusion Diagnostics Market

One of the key market drivers for the global blood transfusion diagnostics market is the increasing prevalence of bloodborne diseases and the rising awareness of safe blood transfusion practices. As infections such as HIV, hepatitis B, and hepatitis C remain significant health concerns worldwide, there is a heightened demand for advanced diagnostic testing to ensure the safety and quality of blood products. This, coupled with the growing emphasis on regulatory compliance and stringent safety protocols in healthcare settings, propels the adoption of innovative blood screening technologies and diagnostic solutions, thereby driving market growth.

Restraints in the Global Blood Transfusion Diagnostics Market

One key market restraint for the global blood transfusion diagnostics market is the high cost associated with advanced diagnostic technologies and equipment. Many healthcare facilities, particularly in developing regions, face budget constraints that limit their ability to invest in cutting-edge blood screening and testing solutions. This financial barrier can impede the implementation of rapid and accurate diagnostic methods, ultimately affecting patient safety and the overall efficiency of blood transfusion services. Additionally, the complexity involved in obtaining regulatory approvals for new diagnostic products further complicates market entry and could stifle innovation within the industry.

Market Trends of the Global Blood Transfusion Diagnostics Market

The Global Blood Transfusion Diagnostics market is witnessing a significant trend towards heightened automation and enhanced digital connectivity. Laboratories are increasingly adopting fully automated platforms, which streamline workflows related to sample manipulation, testing, and result interpretation, thereby improving consistency and reducing turnaround times in high-demand settings like national blood banks and large hospitals. Concurrently, the integration of digital tools such as Laboratory Information Management Systems (LIMS) and cloud-based analytics is gaining momentum, facilitating superior traceability, live tracking, and data sharing across healthcare networks. This digital transformation not only bolsters regulatory compliance but also enhances overall operational efficiency, positioning the market for sustained growth.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technology Assessment
• Regulatory Landscape
• Pipeline Analysis

Global Blood Transfusion Diagnostics Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Instruments
• Kits & Reagents
• Software & Services

Global Blood Transfusion Diagnostics Market Size by Test Type & CAGR (2026-2033)

• Market Overview
• Infectious Disease Screening (TTIs)
• Blood Grouping & Typing
• Compatibility & Cross-match Testing
• Nucleic Acid Testing (NAT)
• Other Transfusion Diagnostics

Global Blood Transfusion Diagnostics Market Size by End-User & CAGR (2026-2033)

• Market Overview
• Blood Banks & Transfusion Services
• Hospitals / Clinical Labs
• Diagnostic Laboratories
• Research Institutes

Global Blood Transfusion Diagnostics Market Size by Technology & CAGR (2026-2033)

• Market Overview
• Serology / Immunoassay
• Molecular Diagnostics (PCR/NAT)
• Next-Generation Sequencing / Advanced Platforms
• Automation & High-Throughput Systems

Global Blood Transfusion Diagnostics Market Size & CAGR (2026-2033)

• North America (Product Type, Test Type, End-User, Technology)
  • US
  • Canada
• Europe (Product Type, Test Type, End-User, Technology)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Test Type, End-User, Technology)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Test Type, End-User, Technology)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Test Type, End-User, Technology)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Grifols, S.A.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche Ltd f
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Quotient Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ortho Clinical Diagnostics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioMerieux SA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Immucor, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BD (Becton, Dickinson & Company)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DiaSorin S.p.A.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BAG Healthcare GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sysmex Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beckman Coulter Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fresenius Kabi AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cepheid
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations